LACTNET Archives

Lactation Information and Discussion

LACTNET@COMMUNITY.LSOFT.COM

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
Janice Reynolds <[log in to unmask]>
Reply To:
Lactation Information and Discussion <[log in to unmask]>
Date:
Fri, 16 May 2003 09:45:16 -0600
Content-Type:
text/plain
Parts/Attachments:
text/plain (36 lines)
Don't know if this was posted yet.
Janice Reynolds


Palm Oil in Infant Formula Blunts Bone Mineralization


By David Douglas

NEW YORK (Reuters Health) May 06 - Use of palm oil and its more liquid fraction, palm olein, to supplement infant formula may adversely affect skeletal development, researchers report in the May issue of Pediatrics.

As lead investigator Dr. Winston W. K. Koo told Reuters Health, "optimization of bone mass can begin during infancy with appropriate nutritional intake," but "infant formulas with similar contents can have different biological outcomes, depending on the ingredients added."

Dr. Koo of Wayne State University, Detroit, and colleagues point out that palm oil and olein "are used in some infant formula fat blends to match the fatty acid profile of human milk." Nevertheless, there is evidence that such additives lower calcium and fat absorption.

To investigate, the researchers conducted a double-blind study of 128 infants who were randomized to receive cow milk-based formulas with or without palm olein. The palm olein-containing formula was Enfamil with iron (Bristol Myers); the palm olein-free was Similac with iron (Abbott Laboratories)

Measurements taken at baseline (2 weeks of age) and at 3 and 6 months showed no significant differences between groups in factors such as weight and formula intake. However, infants fed the palm-containing formula showed significantly lower bone mineral content and bone mineral density at 3 and 6 months.

Matching the fatty acid profile of human milk by using palm olein, the researchers conclude, "may result in an unintended depression of bone mass accretion and may potentially be detrimental to optimal bone health."

Pediatrics 2003;111:1017-1023.


             ***********************************************

To temporarily stop your subscription: set lactnet nomail
To start it again: set lactnet mail (or digest)
To unsubscribe: unsubscribe lactnet
All commands go to [log in to unmask]

The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(TM)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html

ATOM RSS1 RSS2